Az. Osp. S. Maria; Dept. Di Oncologia Medica
About Az. Osp. S. Maria; Dept. Di Oncologia Medica
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
4
Clinical Trials at Az. Osp. S. Maria; Dept. Di Oncologia Medica
During the past decade, Az. Osp. S. Maria; Dept. Di Oncologia Medica conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma
2009-06-29
2015-09-09
Completed
921
A Study of Obinutuzumab in Combination With CHOP Chemotherapy Versus Rituximab With CHOP in Participants With CD20-Positive Diffuse Large B-Cell Lymphoma (GOYA)
2011-07-26
2018-01-31
Terminated
1,418
Comparison of the Treatments of Obinutuzumab + Venetoclax Versus Obinutuzumab + Chlorambucil in Patients With Chronic Lymphocytic Leukemia
2014-12-31
2025-08-31
Active, not recruiting
445
Untreated FolliculaR Lymphoma Treated With OBinituzumAb in a Non-interventional Study (URBAN)
2019-09-02
2024-12-30
Active, not recruiting
299
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Az. Osp. S. Maria; Dept. Di Oncologia Medica"
#1 collaborator was "AbbVie" with 1 trials as a collaborator, "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator and "German CLL Study Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Az. Osp. S. Maria; Dept. Di Oncologia Medica
According to Clinical.Site data, the most researched conditions in "Az. Osp. S. Maria; Dept. Di Oncologia Medica" are
"Diffuse Large B-Cell Lymphoma" (1 trials), "Follicular Lymphoma" (1 trials), "Glioblastoma" (1 trials) and "Lymphocytic Leukemia, Chronic" (1 trials). Many other conditions were trialed in "Az. Osp. S. Maria; Dept. Di Oncologia Medica" in a lesser frequency.
Clinical Trials Intervention Types at Az. Osp. S. Maria; Dept. Di Oncologia Medica
Most popular intervention types in "Az. Osp. S. Maria; Dept. Di Oncologia Medica" are "Drug" (4 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Obinutuzumab" (3 trials), "Bevacizumab" (1 trials), "Chlorambucil" (1 trials), "Cyclophosphamide" (1 trials) and "Doxorubicin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Az. Osp. S. Maria; Dept. Di Oncologia Medica
The vast majority of trials in "Az. Osp. S. Maria; Dept. Di Oncologia Medica" are
4 trials for "All" genders.
Clinical Trials Status at Az. Osp. S. Maria; Dept. Di Oncologia Medica
Currently, there are NaN active trials in "Az. Osp. S. Maria; Dept. Di Oncologia Medica".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Az. Osp. S. Maria; Dept. Di Oncologia Medica,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Az. Osp. S. Maria; Dept. Di Oncologia Medica, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".